GlassScriptPhysician profile
Brenna C Wise
NPI 1528416450
$1,739.93
in general payments reported to CMS, 2019-2025
23 companies · $362 in 2025
The $362 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $295 · 2022: $623 · 2023: $258 · 2024: $202 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $821.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $446.32 | 2021-2023 | |
| Exeltis, USA INC. | $240.36 | 2022-2025 | Slynd |
| Hologic Sales and Service, LLC | $117.63 | 2025 | Aptima |
| Astellas Pharma US INC | $114.92 | 2023-2025 | Veozah |
| Organon LLC | $107.92 | 2022-2024 | Nexplanon |
| Evofem Biosciences, INC. | $106.11 | 2021-2024 | |
| Biogen, INC. | $98.97 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $87.04 | 2021 | |
| Therapeuticsmd, INC. | $76.03 | 2022 | |
| Sumitomo Pharma America, INC. | $48.80 | 2023-2024 | Myfembree |
| Pharmacosmos Therapeutics INC. | $38.78 | 2022 | |
| Coopersurgical, INC. | $38.75 | 2022-2025 | Paragard T 380a |
| Exact Sciences Corporation | $37.56 | 2025 | The Cologuard Plus Collection Kit |
| Myovant Sciences INC. | $25.19 | 2022 | |
| Scynexis, INC. | $22.08 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $21.46 | 2025 | |
| Millicent US INC | $18.89 | 2023 | Intrarosa |
| Avanos Medical | $18.48 | 2022 | |
| Becton, Dickinson and Company | $18.15 | 2022 | |
| Agile Therapeutics, INC. | $14.81 | 2022 | |
| Aspira Women'S Health INC | $14.73 | 2024 | Ova1 |
| Bausch Health US, LLC | $14.69 | 2023 | Aplenzin |
| Davol INC. | $12.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brenna Wise listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.